NCT04271293View on ClinicalTrials.gov

Oral Anti-coagulants in Fragile Patients With Percutaneous Endoscopic Gastrostomy and Atrial Fibrillation (ORIGAMI) Pilot Study

CompletedOBSERVATIONAL
Enrollment

12

Participants

Timeline

Start Date

April 7, 2020

Primary Completion Date

July 20, 2021

Study Completion Date

August 10, 2021

Conditions
Atrial Fibrillation
Interventions
DRUG

Edoxaban

Edoxaban will be administered via PEG in patients who are eligible for the anticoagulant treatment according to the current guidelines.

Trial Locations (1)

00168

Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome

All Listed Sponsors
lead

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

OTHER

NCT04271293 - Oral Anti-coagulants in Fragile Patients With Percutaneous Endoscopic Gastrostomy and Atrial Fibrillation (ORIGAMI) Pilot Study | Biotech Hunter | Biotech Hunter